Dihydrouracil Dehydrogenase (NADP)Dihydropyrimidine Dehydrogenase DeficiencyAntineoplastic Combined Chemotherapy ProtocolsFluorouracilMucositisLeukopeniaAntimetabolites, AntineoplasticCamptothecinAntineoplastic AgentsDrug Administration ScheduleAntineoplastic Agents, PhytogenicToxicity TestsInfusions, IntravenousTreatment OutcomeGlucuronosyltransferaseCisplatinDose-Response Relationship, DrugNeoplasmsCombined Modality TherapyLeucovorinMaximum Tolerated DoseNeutropeniaDrug-Related Side Effects and Adverse ReactionsTaxoidsGastrointestinal DiseasesDeoxycytidineThrombocytopeniaSurvival AnalysisOrganoplatinum CompoundsAdministration, OralCyclophosphamideArea Under CurveToxicity Tests, AcuteEtoposidePaclitaxelDoxorubicinSurvival RateMethotrexateNeoplasm Recurrence, LocalLung NeoplasmsDisease-Free SurvivalColorectal NeoplasmsNeoplasm MetastasisNeoplasm StagingAdenocarcinomaCarcinoma, Non-Small-Cell LungChemotherapy, AdjuvantRetrospective StudiesProspective StudiesRecombinant ProteinsBreast NeoplasmsLethal Dose 50PrognosisToxicity Tests, ChronicNo-Observed-Adverse-Effect LevelCell SurvivalTime FactorsToxicologyDrug EvaluationRadiation InjuriesDrug-Induced Liver InjuryLiverToxicity Tests, SubchronicAntidotesRadiotherapy DosageCarboplatinHematologic DiseasesTeratogensDrug Evaluation, PreclinicalWater Pollutants, ChemicalAnimal Testing AlternativesEnvironmental PollutantsGlutathioneRats, Sprague-DawleyInsecticidesVinblastineRadiotherapyAntineoplastic Agents, AlkylatingDrug InteractionsOrgan SizeCells, CulturedNauseaToxicity Tests, SubacuteNeurotoxicity SyndromesPlant ExtractsDose FractionationVincristineBody WeightAntibiotics, AntineoplasticNanoparticlesRadiotherapy, ConformalAntibodies, MonoclonalCell Line, TumorOxidative StressKidneyAcetaminophenPlant PoisoningApoptosisTissue DistributionDrug Synergism